The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trabectedin (T)-related liver toxicity: Results of a pharmacokinetic study with T in patients with hepatic dysfunction (OVC1004) and experience from a phase 3 clinical trial (SAR3007).
 
Emiliano Calvo
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; Lilly/ImClone; Nanobiotix; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Novartis
Research Funding - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Janssen Oncology; Lilly; Merck; Millennium; Nektar; Novartis; OncoMed; Pfizer; PharmaMar; PsiOxus Therapeutics; Puma Biotechnology; Roche/Genentech; Sanofi; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Lilly; Novartis; PsiOxus Therapeutics
Other Relationship - Pierre Fabre
 
Analia Azaro
No Relationships to Disclose
 
Luc Dirix
No Relationships to Disclose
 
Manon Huizing
No Relationships to Disclose
 
Francis Mark Senecal
No Relationships to Disclose
 
Patricia LoRusso
Consulting or Advisory Role - Astellas Pharma; Astex Pharmaceuticals; Genentech; Novartis
Speakers' Bureau - Genentech
Research Funding - Genentech (Inst); Immunogen (Inst); Merrimack (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Tensha Therapeutics (Inst)
 
Lorrin Yee
No Relationships to Disclose
 
Chi Fung Keung
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Spyros Triantos
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Youn C. Park
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Roland Elmar Knoblauch
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
Trilok V. Parekh
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen Research & Development
 
George D. Demetri
Leadership - Blueprint Medicines; Caris Life Sciences; Champions Oncology; G1 Therapeutics; Kolltan Pharmaceuticals
Stock and Other Ownership Interests - Bessor Pharma; Blueprint Medicines; Caris Life Sciences; Champions Oncology; G1 Therapeutics; Kolltan Pharmaceuticals
Consulting or Advisory Role - ARIAD; Bayer; Bessor Pharma; Blueprint Medicines; Caris Life Sciences; Champions Oncology; Daiichi Sankyo; EMD Serono; G1 Therapeutics; Genocea Biosciences; Janssen; Kolltan Pharmaceuticals; Kyocera; Lilly; Nektar; Novartis; Pfizer; PharmaMar; Polaris; Sanofi; WIRB-Copernicus Group; ZIOPHARM Oncology
Research Funding - Bayer (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Novartis
 
Margaret vonMehren
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis